kajol glutathione treatment 10 years ago, had noticeably dull and tanned skin…, And today, her skin looks much brighter and clearer., She says it’s because she used to shoot under the sun without sunscreen, which caused Kajol got skin-lightening treatment? Know

This classification prohibits its use by athletes both in and out of competition

Injectable peptides may be detectable longer than oral or topical forms due to different pharmacokinetic profiles

What can Vitamin B12 Injections help with

What is Peptide BPC-157 BPC-157 stands for Body Protection Compound 157, and it is a synthetic peptide derived from a protein found in the stomach

If you cannot reliably draw 4 units, use more water

Summary of REDEFINE 1 and REDEFINE 2 trials with CagriSema, presented this week at #ADA2025 and published in NEJM: REDEFINE 1: 3,417 participants with obesity or overweight (without diabetes) treated with CagriSema achieved a 22.7% weight loss after 68 weeks, compared to 2.3% with placebo 40.4% of participants on CagriSema achieved a weight loss of 25% or more The weight loss was slightly below the company's initial expectations of at least 25% REDEFINE 2: 1,206 participants with obesity or overweight and type 2 diabetes treated with CagriSema achieved a 15.7% weight loss after 68 weeks, best in the category thus far , compared to 3.1% with placebo 89.7% of participants achieved a weight loss of 5% or more Mean HbA1c reduction of 2.07% Article links: nejm.org/doi/full/10.10 nejm.org/doi/full/10.10 Summary of REDEFINE 1 and REDEFINE 2 trials with CagriSema, presented this week at #ADA2025 and published in NEJM: REDEFINE 1: 3,417 participants with obesity or overweight (without diabetes) treated with CagriSema achieved a 22.7% weight loss after 68 weeks, compared to 2.3% with placebo 40.4% of participants on CagriSema achieved a weight loss of 25% or more The weight loss was slightly below the company's initial expectations of at least 25% REDEFINE 2: 1,206 participants with obesity or overweight and type 2 diabetes treated with CagriSema achieved a 15.7% weight loss after 68 weeks, best in the category thus far , compared to 3.1% with placebo 89.7% of participants achieved a weight loss of 5% or more Mean HbA1c reduction of 2.07% Article links: nejm.org/doi/full/10.10 nejm.org/doi/full/10.10 Hopefully primary prevention in normal weight is next Pharma has obesity in its sights